3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing

[1]  M. Löhr,et al.  3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing , 2013, BMC Cancer.

[2]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[3]  P. Devilee,et al.  The Warburg effect in 2012 , 2012, Current opinion in oncology.

[4]  J. Jacob,et al.  microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma , 2011, Expert review of anticancer therapy.

[5]  Franziska Hirschhaeuser,et al.  Lactate: a metabolic key player in cancer. , 2011, Cancer research.

[6]  W. El-Rifai,et al.  DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. , 2011, Gastroenterology.

[7]  Martin Enge,et al.  Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53 , 2011, The Journal of Biological Chemistry.

[8]  Min Wang,et al.  Inhibitory effects of miR-146b-5p on cell migration and invasion of pancreatic cancer by targeting MMP16 , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[9]  C. Haslinger,et al.  Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. , 2011, The American journal of pathology.

[10]  B. Vangamudi,et al.  Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells , 2011, Molecular Cancer.

[11]  S. Dangi‐Garimella,et al.  Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. , 2011, Cancer research.

[12]  Gautam Munglani,et al.  Biomimetic microenvironment modulates neural stem cell survival, migration, and differentiation. , 2010, Tissue Engineering. Part A.

[13]  W. Hagmann,et al.  Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. , 2010, Neoplasia.

[14]  T. Dyke.  Finding the tumor copycat: Approximating a human cancer , 2010, Nature Medicine.

[15]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.

[16]  Yong-Tae Kim,et al.  Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer , 2010, PloS one.

[17]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[18]  K. Uzawa,et al.  Identification of cisplatin‐resistance related genes in head and neck squamous cell carcinoma , 2010, International journal of cancer.

[19]  S. Kane,et al.  Darpp-32 and Its Truncated Variant t-Darpp Have Antagonistic Effects on Breast Cancer Cell Growth and Herceptin Resistance , 2009, PloS one.

[20]  M. Ringuette,et al.  Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype , 2009, International journal of cancer.

[21]  Qizhi Yao,et al.  Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis , 2009, World Journal of Surgery.

[22]  R. Jesenofsky,et al.  ATP-Binding Cassette C Transporters in Human Pancreatic Carcinoma Cell Lines , 2008, Pancreatology.

[23]  A. Tsatsakis,et al.  Lumican, a small leucine‐rich proteoglycan , 2008, IUBMB life.

[24]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[25]  S. Sahoo,et al.  3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.

[26]  G. Sommer,et al.  Reference , 2008 .

[27]  Helmut Friess,et al.  Pancreatic cancer microenvironment , 2007, International journal of cancer.

[28]  J. Abbruzzese,et al.  Establishment of three-dimensional cultures of human pancreatic duct epithelial cells. , 2007, Biochemical and biophysical research communications.

[29]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[30]  I. Tannock,et al.  The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.

[31]  Avital Schurr,et al.  Lactate: The Ultimate Cerebral Oxidative Energy Substrate? , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  J. Kleeff,et al.  Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine , 2005, Laboratory Investigation.

[33]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[34]  K. Beningo,et al.  Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Gessler,et al.  Cloning and expression analysis of the mouse stroma marker Snep encoding a novel nidogen domain protein , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[36]  James P. Freyer,et al.  The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.

[37]  P. Limtrakul,et al.  Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids , 2004, BMC Cancer.

[38]  K. Tsuchida,et al.  Tumor-Stroma Interaction of Human Pancreatic Cancer: Acquired Resistance to Anticancer Drugs and Proliferation Regulation Is Dependent on Extracellular Matrix Proteins , 2004, Pancreas.

[39]  S. Corbett,et al.  Fibronectin Matrix Assembly Regulates α5β1-mediated Cell Cohesion , 2003 .

[40]  W. Dalton,et al.  Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death , 2003, Oncogene.

[41]  S. Pandol,et al.  Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. , 2003, Gastroenterology.

[42]  G. Peters,et al.  Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines , 2003, British Journal of Cancer.

[43]  M. Löhr,et al.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform , 2003, Virchows Archiv.

[44]  F. Real,et al.  Genetic profile of 22 pancreatic carcinoma cell lines , 2001, Virchows Archiv.

[45]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[46]  Stefan Walenta,et al.  Metabolic Imaging in Multicellular Spheroids of Oncogene-transfected Fibroblasts , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  B. Nebe,et al.  CD44, bFGF and Hyaluronan in Human Pancreatic Cancer Cell Lines , 1999, Annals of the New York Academy of Sciences.

[48]  J. Sleeman,et al.  Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. , 1996, Cancer research.

[49]  M. Löhr,et al.  Expression and Function of Receptors for Extracellular Matrix Proteins in Human Ductal Adenocarcinomas of the Pancreas , 1996, Pancreas.

[50]  P. Olive,et al.  Drug and radiation resistance in spheroids: cell contact and kinetics , 1994, Cancer and Metastasis Reviews.

[51]  M. Löhr,et al.  Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. , 1994, British Journal of Cancer.

[52]  T. Christensen,et al.  Ultrastructural Differentiation and CEA Expression of Butyrate‐Treated Human Pancreatic Carcinoma Cells , 1987, Pancreas.

[53]  J. Carlsson,et al.  Demonstration of an extracellular matrix in multicellular tumor spheroids. , 1984, Cancer research.

[54]  M. Sarosdy,et al.  Prediction of Response to Cancer Chemotherapy , 1983, Drugs.

[55]  E. Diamandis,et al.  Pancreatic cancer. , 2013, Clinical chemistry.

[56]  Zhiwei Wang,et al.  Pancreatic cancer: understanding and overcoming chemoresistance , 2011, Nature Reviews Gastroenterology &Hepatology.

[57]  John W Haycock,et al.  3D cell culture: a review of current approaches and techniques. , 2011, Methods in molecular biology.

[58]  Xin Wang 王 欣,et al.  Inhibitory effects of miR-146b-5p on cell migration and invasion of pancreatic cancer by targeting MMP16 , 2011, Journal of Huazhong University of Science and Technology [Medical Sciences].

[59]  J. Haier,et al.  MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. , 2010, European journal of cancer.

[60]  Juergen Friedrich,et al.  Spheroid-based drug screen: considerations and practical approach , 2009, Nature Protocols.

[61]  S. Corbett,et al.  Fibronectin matrix assembly regulates alpha5beta1-mediated cell cohesion. , 2004, Molecular biology of the cell.

[62]  J. Ringel,et al.  Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. , 2001, Cancer research.

[63]  J. Ringel,et al.  Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma , 2001 .